Seoul, South Korea

Kyungjin Kim

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 43(Granted Patents)


Location History:

  • Seoul, KR (2013 - 2022)
  • Siheung-si, KR (2019 - 2023)

Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kyungjin Kim

Introduction

Kyungjin Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. With a total of nine patents to his name, Kim's work has the potential to impact the treatment of viral infections.

Latest Patents

Among his latest patents, Kim has developed novel nucleoside or nucleotide derivatives that serve as active ingredients in pharmaceutical compositions aimed at preventing or treating viral infection-associated diseases. This innovative work highlights the importance of his research in combating viral infections. Additionally, he has created a pyrrolopyridine derivative that demonstrates high selectivity and antiviral activity against human immunodeficiency virus (HIV), while maintaining low toxicity. This compound is particularly useful as a therapeutic agent for HIV infection.

Career Highlights

Kyungjin Kim has worked with notable companies such as LG Electronics Inc. and ST Pharm Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Throughout his career, Kim has collaborated with talented individuals, including Jiyoung Hong and Sungeun Kim. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful inventions.

Conclusion

Kyungjin Kim's contributions to the field of pharmaceuticals through his innovative patents and collaborations underscore his importance as an inventor. His work continues to pave the way for advancements in the treatment of viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…